| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Agios Pharmaceuticals, Inc. (AGIO) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. AGIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 149.1K | $5.30M | - | |
| Other | 67.7K | $2.41M | - | |
| CFO | 40.3K | $1.44M | - | |
| Other | 34.6K | $1.23M | - | |
| Dir | 17.8K | $633.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 2, 2015 | Biller Scott | Chief Scientific Officer | Sale+OE | 5,500 | $77.12 | $424,160.00 | -13.9% | |
| Oct 27, 2015 | Schenkein David P59 | Chief Executive Officer | Sale+OE | 4,000 | $80.26 | $321,040.00 | -1.7% | |
| Oct 23, 2015 | Cantley Lewis Clayton Jr. | Director | Sell | 9,704 | $61.16 | $593,496.64 | -1.7% | |
| Oct 15, 2015 | Higgons John Duncan | Chief Operating Officer | Sale+OE | 20,000 | $71.04 | $1,420,800.00 | -19.6% | |
| Sep 30, 2015 | Biller Scott | Chief Scientific Officer | Sale+OE | 5,500 | $70.44 | $387,420.00 | -13.9% | |
| Sep 25, 2015 | Cantley Lewis Clayton Jr. | Director | Sell | 9,704 | $83.25 | $807,882.26 | -1.6% | |
| Sep 24, 2015 | Goddard Glenn83 | Senior Vice President, Finance | Sale+OE | 6,000 | $85.97 | $515,820.00 | -100% | |
| Sep 15, 2015 | Higgons John Duncan | Chief Operating Officer | Sale+OE | 20,000 | $91.11 | $1,822,200.00 | -12.4% | |
| Aug 18, 2015 | Cantley Lewis Clayton Jr. | Director | Sell | 9,704 | $94.94 | $921,322.02 | -1.6% | |
| Aug 17, 2015 | Higgons John Duncan | Chief Operating Officer | Sale+OE | 20,000 | $92.24 | $1,844,800.00 | -13.2% |